Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective silencing of placental anti-angiogenic factors in invasive trophoblasts via membrane-fusion divalent siRNA delivery for preeclampsia therapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Lysosome-directed targeted protein degradation technologies for overcoming cancer drug resistance: mechanisms, design principles, and therapeutic opportunities.

Drug delivery·2026
Same author

Advances in nanotechnology for the diagnosis and management of autoimmune diseases.

Asian journal of pharmaceutical sciences·2026
Same author

Placenta-oriented self-assembled Aspirin-RGDV nanoconjugates attenuate preeclampsia through restoration of angiogenic balance.

International journal of pharmaceutics: X·2026
Same author

Prognostic Value of the Nutritional Risk Index and Hemoglobin-to-Platelet Ratio Score for Predicting Recurrence and Survival in Siewert II/III Gastroesophageal Junction Adenocarcinoma.

Journal of gastrointestinal cancer·2026
Same author

Enhancing genomic prediction accuracy in Huaxi cattle through integration of transcriptomic data and a self-attention-based SNP selection strategy.

BMC bioinformatics·2026

Related Experiment Video

Updated: Jun 17, 2026

Fabricating Highly Open Porous Microspheres (HOPMs) via Microfluidic Technology
05:21

Fabricating Highly Open Porous Microspheres (HOPMs) via Microfluidic Technology

Published on: May 16, 2022

A one-step modified method to reduce the burst initial release from PLGA microspheres.

Caihong Zheng1, Wenquan Liang

  • 1Women's Hospital Affiliated College of Medical Sciences, Zhejiang University, Hangzhou 310006, PR China. chzheng@zju.edu.cn

Drug Delivery
|January 14, 2010
PubMed
Summary

This study modified poly(lactic-co-glycolic acid) (PLGA) microspheres using alginate, calcium chloride, and chitosan. The modified PLGA microspheres significantly reduced initial protein burst release and closed surface pores.

More Related Videos

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
12:48

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

Related Experiment Videos

Last Updated: Jun 17, 2026

Fabricating Highly Open Porous Microspheres (HOPMs) via Microfluidic Technology
05:21

Fabricating Highly Open Porous Microspheres (HOPMs) via Microfluidic Technology

Published on: May 16, 2022

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
12:48

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Polymer Chemistry

Background:

  • Poly(lactic-co-glycolic acid) (PLGA) microspheres are widely used for controlled protein delivery.
  • A significant challenge is the initial burst release of entrapped proteins, which can lead to adverse effects.
  • Developing strategies to mitigate this burst release is crucial for improving therapeutic efficacy.

Purpose of the Study:

  • To evaluate a one-step modified method for entrapping bovine serum albumin (BSA) into PLGA microspheres.
  • To reduce the initial burst release of BSA from PLGA microspheres.
  • To assess the impact of the modification on entrapment efficiency and particle size.

Main Methods:

  • A modified one-step method was employed involving the addition of alginate to the internal aqueous phase with BSA.
  • Calcium chloride and chitosan were incorporated into the external phase.
  • Standard procedures were maintained for other process parameters.

Main Results:

  • The modified PLGA microspheres exhibited a marked inhibition of initial protein release.
  • A slight increase in entrapment efficiency was observed.
  • Particle size remained unchanged after the modification.
  • Scanning electron microscopy (SEM) revealed the closure of surface pores on the modified microspheres.

Conclusions:

  • The one-step modification effectively reduces the initial burst release of proteins from PLGA microspheres.
  • This method offers a promising approach for enhancing protein delivery systems by improving drug loading and controlling release kinetics.
  • The observed pore closure suggests a mechanism for improved drug retention within the microspheres.